Home
About Us
Our Products
Our Science
Contact Us
News

PRODUCTSDon’t worry, we have it

Bring to the table win-win survival strategies to ensure proactive domination. At the end of the day, going forward.

bt_bb_section_bottom_section_coverage_image

Recent Posts

July 26, 2022ERS Genomics and Lepton Pharmaceuticals LTD Enter CRISPR/Cas9 License Agreement
February 14, 2022Lepton signs Consulting Agreement with Cell Therapy Expert Dr. Elena Sotillo, Senior Research Scientist at the lab of Prof. Crystal Mackall founding director, Center for Cancer Cell Therapy, Stanford Cancer Institute, Palo Alto, Ca, USA
February 4, 2022Prof. Malcolm K Brenner, M.D., Ph.D. Founding Director of Baylor College of Medicine’s Center for Cell and Gene Therapy Houston, TX US agreed to consult to Lepton
February 1, 2022Lepton signs Consulting Agreement with Dr. Paz Einat
December 2, 2021Lepton announces filing of a PCT application covering its proprietary breakthrough Castling Technology

https://www.leptonpharma.com/wp-content/uploads/2021/04/logo_white_big-160x160.png

© 2021 Lepton Pharmaceuticals Inc. All rights reserved

Our products

LN-Cast-01
LN-008 siMASP2

Our science

Castling Technology
siRNA and miRNA
Non-coding RNA
siRNA Advantages

Terms of use

Terms of Use
Copyright Info
Privacy Policy